Vaccitech plc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Vaccitech plc. | VACC - NASDAQ |
$16.00-$18.00 | $17.00 | $13.62 | 6.5 million ADSs | 4/30/2021 |
| Morgan Stanley, Jefferies, Barclays, William Blair | ||||||
Co-Manager(s): H.C. Wainwright | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-04-09 Terms Added 2021-04-26 | ||||||
Vaccitech plc. Quote & Chart - Click for current quote - VACC
IPO Boutique aggregates information on public companies and private companies, such as "VACC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Vaccitech plc. (adapted from Vaccitech plc. prospectus):
They are a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "VACC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.